ALLYLAMINE CARDIOVASCULAR TOXICITY .5. TISSUE DISTRIBUTION AND TOXICOKINETICS AFTER ORAL-ADMINISTRATION

被引：15

作者：

BOOR, PJ

机构：

来源：

关键词：

D O I：

10.1016/0300-483X(85)90013-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：167 / 177

页数：11

共 26 条

[1] ALLYLAMINE CARDIOTOXICITY .3. PROTECTION BY SEMI-CARBAZIDE AND INVIVO DERANGEMENTS OF MONOAMINE-OXIDASE
BOOR, PJ
NELSON, TJ
[J]. TOXICOLOGY, 1980, 18 (02) : 87 - 102
[2] ALLYLAMINE CARDIOTOXICITY .1. SEQUENCE OF PATHOLOGIC EVENTS
BOOR, PJ
MOSLEN, MT
REYNOLDS, ES
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 50 (03) : 581 - 592
[3] BOOR PJ, 1982, LAB INVEST, V47, P76
[4] BOOR PJ, 1981, TOXICOLOGIST, V1, P53
[5] BOOR PJ, 1983, J MOL CELL CARDIOL, V14, P679
[6] COLBURN WA, 1981, J PHARMACOKINET BIOP, V9, P387
[7] HISTOCHEMICAL EVALUATION OF CANINE CORONARY ARTERY AND AORTIC LESIONS INDUCED BY INTRAVENOUS ALLYLAMINE
CONRAD, LL
GONZALEZ, IE
JOEL, W
FURMAN, RH
[J]. CIRCULATION RESEARCH, 1956, 4 (03) : 263 - 267
[8] CONSTANTINIDES P, 1969, ARCH PATHOL, V88, P106
[9] EPPINGER H, 1934, KLIN WOCHENSCHR, V13, P1105
[10] Gibaldi M, 1982, PHARMACOKINETICS, P433